FAQ’s
Fatty liver disease involves excess fat accumulation in the liver. It is often associated with obesity, diabetes, high cholesterol and other metabolic risk factors, although it can occur in people without these conditions.
NASH, now commonly referred to as metabolic dysfunction-associated steatohepatitis (MASH) in the relevant metabolic context, is a form of fatty liver disease involving liver inflammation and cell injury. It can progress to fibrosis and cirrhosis in some patients.
Yes. Many people with fatty liver disease feel completely well. The condition may be discovered through blood tests or imaging performed for another reason.
Yes. For many patients, gradual weight loss when appropriate, regular physical activity, balanced nutrition and control of diabetes and cholesterol can reduce liver fat and improve metabolic health.
Assessment may include liver blood tests, ultrasound, fibrosis scoring, elastography or other investigations. A liver biopsy is sometimes needed when non-invasive tests do not provide sufficient information.
